AlphaFold predicted structure
P2RX1 · P51575

Mean pLDDT
87.8/ 100
Confident
399 residues
Confidence breakdown
- Very high(≥ 90)62%
- Confident(70–90)29%
- Low(50–70)8%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
purinergic receptor P2X 1
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Bleeding and platelet disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownplacental abruption
platelet-type bleeding disorder 8
breast cancer
acute lymphoblastic leukemia
colitis
acute myeloid leukemia
spermatogenic failure
non-syndromic male infertility due to sperm motility disorder
partial chromosome Y deletion
male infertility with azoospermia or oligozoospermia due to single gene mutation
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
P2X purinoceptor 1
ATP-gated nonselective transmembrane cation channel permeable to potassium, sodium and with relatively high calcium permeability (PubMed:10440098, PubMed:15056721, PubMed:20699225, PubMed:8834001, PubMed:8961184). Furthermore, CTP functions as a weak affinity agonist for P2RX1 (PubMed:14699168). Plays a role a role in urogenital, immune and cardiovascular function (By similarity). Specifically, plays an important role in neurogenic contraction of smooth muscle of the vas deferens, and therefore is essential for normal male reproductive function (By similarity). In addition, contributes to smooth muscle contractions of the urinary bladder (By similarity). On platelets, contributes to platelet activation and aggregation and thereby, also to thrombosis (By similarity). On neutrophils, it is involved in chemotaxis and in mitigating the activation of circulating cells (PubMed:19635923)
P2RX1 · P51575

Mean pLDDT
87.8/ 100
Confident
399 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0